Continuum of Care in Pain Management: Bridging the Gap (Part 2 of 4) Case 2: Assessing and Managing a Patient with Chronic Neuropathic Pain
neuroscienceCME Medical Simulation
Premiere Date: Monday, October 31, 2011This activity offers CE credit for:
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Wednesday, October 31, 2012
Note: Credit Is No Longer Available
 | Lesley M. Arnold, MD Professor of Psychiatry and Behavioral Neuroscience Director, Women's Health Research Program University of Cincinnati College of Medicine Cincinnati, OH |
In a nationwide survey, 75% of individuals with recent moderate to severe pain had seen a doctor for their pain, yet less than half of those (44%) had received adequate pain control. In a nation with increasing prevalence of diabetic disease,(1) many clinicians need more information regarding the pathophysiology of pain present in diabetic peripheral neuropathy (DPN).
Although guidelines for DPN diagnosis and management exist(2) and numerous pharmacological agents are approved to treat various forms of chronic pain, a gap exists regarding firm DPN diagnosis that would allow clinicians to incorporate evidence- and outcomes-based treatment. Because of the effects of pain on sleep and vice versa, comprehensive management of DPN requires investigation into sleep hygiene, an underperformed assessment in its own right. Physicians and their medical teams play an important role in educating patients, families, and caregivers, regarding optimal strategies for managing diabetes and DPN.
This neuroscienceCME Medical Simulation addresses pain assessment and tailored, multimodal management of DPN, as well strategies for patient education and coordinating the optimal management of care across the continuum.
- Albright A. Statement by Ann Albright, Director, Division of Diabetes Translation, on National Center for Chronic Disease Prevention and Health Promotion before Committee on Energy and Commerce, Subcommittee on Health, United States House of Representatives [testimony]. Department of Health and Human Services Website. http://www.hhs.gov/asl/testify/2010/07/t20100701a.html. Revised April 19, 2011. Accessed August 11, 2011.
- Argoff CE, Backonja M-M, et al. Consensus guidelines: treatment planning and options. Mayo Clin Proc. 2006;81:S12-S25.
Address gaps in the diagnosis and multimodal management of diabetic peripheral neuropathy and any comorbid occurrence of poor sleep health.
At the end of this CE activity, participants should be able to:
- Establish a firm diagnosis of diabetic peripheral neuropathy (DPN) based on clinical and laboratory findings that also rules out other potential causes of peripheral pain.
- Assess for sleep disturbances in patients with chronic pain and treat any diagnoses in a tailored treatment plan to improve sleep health.
- Design and institute a multimodal treatment plan for diabetic peripheral neuropathy that includes use of pharmacologic agents recommended by consensus guidelines, appropriate patient education, and control of underlying diabetic illness.
Supported in part by an educational grant from Endo Pharmaceuticals.
This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
Supported in part by Purdue Pharma L.P.
Physicians, physician assistants, nurse practitioners, nurses, pharmacists, and other nonphysician health care professionals interested in chronic neuropathic pain.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.0 contact hours
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Activity Number: 0376-0000-11-016-H01-P (recorded program)
Activity Type: application-based
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/test (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, have evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Arnold has disclosed that she receives grants/research support from Boehringer Ingelheim Pharmaceuticals, Inc., Cypress Bioscience, Inc., Eli Lilly and Company, Forest Laboratories, Inc., and Novartis. She serves as a consultant to AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Cypress Bioscience, Inc., Eli Lilly and Company, Forest Laboratories, Inc., Pfizer Inc., sanofi-aventis, Takeda Pharmaceuticals North America, Inc., Grunenthal, Johnson & Johnson, and Wyeth Pharmaceuticals.
Tony Graham, MD (content/peer reviewer) has no disclosures to report.
Ruth Cody, BSN, RN-BC (content/peer reviewer) has no disclosures to report.
Nancy Jennings, MSN, MBA, MHA, RNC (content/peer reviewer) has no disclosures to report.
Joy Bartnett Leffler, MLA, NASW, CSE (planning committee) has no disclosures to report.
Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.
Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
CME Outfitters, LLC, the faculty, Endo Pharmaceuticals, Lilly USA, LLC, and Purdue Pharma L.P. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
PL-026-103111-90
